Long-term outcomes of a novel initial regimen: Rituximab plus pegylated interferon α-2b in untreated advanced indolent B-cell lymphoma – 5-year follow-up of the ripple study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Yan Gao, Li-Qin Ping, Jianqiu Wu, Yunhong Huang, Hui Zhou, Ru Feng, Huiqiang Huang
Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Jiangsu Cancer Hospital, Guizhou Cancer Hospital, Hunan Cancer Hospital, Nanfang Hospital, Southern Medical University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417012967
Cites:
Cited by:
Related to: